GlassScriptPhysician profile
Yvonne O Latimer
NPI 1841300662
$3,576.65
in general payments reported to CMS, 2019-2025
43 companies · $628 in 2025
The $628 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $175 · 2021: $338 · 2022: $396 · 2023: $533 · 2024: $726 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,887.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $483.19 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $386.17 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $312.68 | 2021-2024 | |
| Lilly USA, LLC | $206.83 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $193.74 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $184.72 | 2019-2023 | Spravato |
| Glaxosmithkline, LLC. | $153.67 | 2019-2025 | Trelegy Ellipta |
| Genentech USA, INC. | $141.17 | 2019 | |
| Astellas Pharma US INC | $139.40 | 2019-2023 | Veozah |
| Amgen INC. | $136.38 | 2019-2025 | Repatha, Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.41 | 2023-2025 | Xifaxan |
| Intuity Medical INC | $90.87 | 2022 | |
| Inari Medical, INC. | $82.08 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Inogen, INC. | $79.60 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Exact Sciences Corporation | $74.43 | 2023-2025 | Cologuard Collection Kit |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvonne Latimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.